Raia Drogasil Balance Sheet Health
Financial Health criteria checks 4/6
Raia Drogasil has a total shareholder equity of R$6.3B and total debt of R$3.3B, which brings its debt-to-equity ratio to 51.8%. Its total assets and total liabilities are R$22.0B and R$15.6B respectively. Raia Drogasil's EBIT is R$2.4B making its interest coverage ratio 3.1. It has cash and short-term investments of R$410.5M.
Key information
51.8%
Debt to equity ratio
R$3.27b
Debt
Interest coverage ratio | 3.1x |
Cash | R$410.51m |
Equity | R$6.32b |
Total liabilities | R$15.64b |
Total assets | R$21.96b |
Recent financial health updates
Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Recent updates
Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings
Nov 26Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Returns Are Gaining Momentum At Raia Drogasil (BVMF:RADL3)
Sep 25Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For
Jul 13Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors
Dec 29Financial Position Analysis
Short Term Liabilities: RADL3's short term assets (R$12.9B) exceed its short term liabilities (R$9.3B).
Long Term Liabilities: RADL3's short term assets (R$12.9B) exceed its long term liabilities (R$6.3B).
Debt to Equity History and Analysis
Debt Level: RADL3's net debt to equity ratio (45.3%) is considered high.
Reducing Debt: RADL3's debt to equity ratio has increased from 30.9% to 51.8% over the past 5 years.
Debt Coverage: RADL3's debt is well covered by operating cash flow (72.1%).
Interest Coverage: RADL3's interest payments on its debt are well covered by EBIT (3.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 06:26 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Raia Drogasil S.A. is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Georgia Jorge | BB Banco de Investimento S.A. |
Robert Ford Aguilar | BofA Global Research |
Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |